This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Eli Ayers | |
|---|---|
| Name | Eli Ayers |
| Occupation | Physician; Researcher |
| Known for | Clinical trials; Addiction medicine; Public health research |
Eli Ayers is an American physician and researcher known for contributions to clinical trial design, addiction medicine, and public health policy. Ayers has worked at leading academic and governmental institutions, collaborating across medicine, public policy, and epidemiology. His career spans clinical practice, randomized controlled trials, and health services research with influence on practice guidelines and regulatory decisions.
Ayers grew up in the United States and completed undergraduate studies before pursuing medical and public health training. He earned an M.D. and a Master of Public Health, training at institutions associated with clinical medicine and population health. His formative mentors included faculty from major academic centers and national research organizations, shaping his interdisciplinary approach that bridged clinical practice, health policy, and statistical methods.
Ayers held faculty and staff positions at universities, specialty hospitals, and federal agencies, contributing to translational research and clinical trials. He collaborated with investigators affiliated with Harvard Medical School, Yale School of Medicine, Johns Hopkins University, Columbia University, University of California, San Francisco, Massachusetts General Hospital, Brigham and Women's Hospital, Veterans Health Administration, Centers for Disease Control and Prevention, and National Institutes of Health. His research integrated methods from randomized trials, observational cohort studies, and cost-effectiveness analysis to address questions in addiction treatment, infectious disease, and behavioral health.
Ayers co-led multicenter trials and served on data safety monitoring boards for studies funded by organizations such as National Institute on Drug Abuse, Patient-Centered Outcomes Research Institute, Robert Wood Johnson Foundation, and state health departments. He worked with collaborators from Kaiser Permanente, Geisel School of Medicine at Dartmouth, Stanford Medicine, University of Pennsylvania Perelman School of Medicine, and Yale School of Public Health. His methodological contributions included adaptive trial designs, pragmatic trial conduct, and integration of electronic health record data from systems like Epic Systems into research workflows.
Ayers authored and co-authored peer-reviewed articles in high-impact journals and presented findings at major conferences. His publications addressed effectiveness of medication-assisted treatment, interventions for opioid use disorder, and strategies to reduce overdose mortality. He contributed to systematic reviews and meta-analyses cited by panels convened by Substance Abuse and Mental Health Services Administration, World Health Organization, American Medical Association, American Society of Addiction Medicine, and specialty societies such as American College of Physicians.
Among his notable works were clinical trial reports comparing pharmacotherapies and behavioral interventions, health services studies on access to care in safety-net settings, and policy analyses on prescribing guidelines and harm reduction. These publications appeared in journals associated with New England Journal of Medicine, JAMA, The Lancet, Addiction (journal), BMJ, and specialty outlets in psychiatry and public health. He contributed chapters in textbooks used in training at institutions like Johns Hopkins Bloomberg School of Public Health and Harvard T.H. Chan School of Public Health.
Ayers received recognition from academic and professional organizations for research excellence and clinical leadership. Honors included early career awards from societies such as Society for Academic Emergency Medicine, American Public Health Association, and Association for Medical Education and Research in Substance Abuse. He earned research grants and career development awards from National Institute on Drug Abuse and philanthropic support from foundations including Gates Foundation and Robert Wood Johnson Foundation. Institutional awards acknowledged mentorship and contributions to translational research at centers affiliated with Massachusetts General Hospital and Yale New Haven Hospital.
Ayers balances clinical and research responsibilities with family life and community engagement. He has volunteered with local health programs and harm reduction initiatives, collaborating with community-based organizations and public health departments. Outside medicine, he has interests in mentorship, education, and interdisciplinary collaboration across health services, policy institutes, and academic networks.
Ayers' work influenced clinical practice, policy deliberations, and research methodology in addiction medicine and public health. His trials and health services research informed guidance from regulatory and advisory bodies including Food and Drug Administration, Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Administration, and professional societies such as American Society of Addiction Medicine and American Psychiatric Association. His emphasis on pragmatic trial designs and integration of electronic health record data has been adopted by investigators at institutions like RAND Corporation, Kaiser Permanente, University of California system, and Yale School of Medicine.
Collaborators and trainees at Harvard T.H. Chan School of Public Health, Johns Hopkins University, Columbia University Mailman School of Public Health, and other centers continue to build on his approaches to comparative effectiveness research and implementation science. Ayers' contributions helped shape policy discussions on medication-assisted treatment access, overdose prevention, and delivery of services for marginalized populations, influencing programs at municipal, state, and federal levels.
Category:Physicians Category:Medical researchers